Hims & Hers Health (HIMS) Non Operating Income (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Non Operating Income came in at -$23.2 million in Q1 2026, down 994.07% year-on-year from $2.6 million in Q1 2025, and down 1607.33% quarter-over-quarter from $1.5 million in Q4 2025.
Hims & Hers Health (HIMS) Non Operating Income (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Non Operating Income across 8 years of filings, most recently posting -$23.2 million for Q1 2026.
- Non Operating Income for Q1 2026 came in at -$23.2 million, down 994.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.5 million (down 175.86% YoY), and the FY2025 annual result was $18.3 million, up 86.69% from the prior year.
- Non Operating Income came in at -$23.2 million for Q1 2026 at Hims & Hers Health, down from $1.5 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $8.0 million in Q3 2025 to a low of -$23.2 million in Q1 2026.
- The 5-year median for Non Operating Income is $1.9 million (2023), against an average of $1.0 million.
- Across the five-year window, Non Operating Income surged 559.72% in 2025 and plunged 994.07% in 2026, its largest moves.
- Hims & Hers Health's Non Operating Income stood at $1.6 million in 2022, then surged by 64.57% to $2.6 million in 2023, then surged by 41.3% to $3.7 million in 2024, then sank by 58.29% to $1.5 million in 2025, then tumbled by 1607.33% to -$23.2 million in 2026.
- The last three Non Operating Income figures came in at -$23.2 million (Q1 2026), $1.5 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -4.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.23 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 8.04 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 523,000.00 |
| Mar 31, 2022 | 761,000.00 |
| Dec 31, 2021 | -9.68 Mn |
| Sep 30, 2021 | 8.55 Mn |
| Jun 30, 2021 | 325,000.00 |